Mucormycosis in cancer patients - an emerging threat

Recently, Mucormycosis has caught attention due to a spike in its incidence in post covid cases, however, for Oncologists and cancer patients, the risk has always been there. Among cancer patients, the most commonly affected are hematological cancer or more commonly known as ‘blood cancer patients, and the bone marrow transplant recipients. Patients receiving chemotherapy and advanced-stage cancer patients are also at risk for mucormycosis.